Highline Wealth Partners’s Idexx Laboratories IDXX Stock Holding History

Highline Wealth Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.26K	Sell	10 -11	-52%	-$6.17K	﹤0.01%	851
2026 Q1	$11.8K	Buy	21 +16	+320%	+$10.3K	﹤0.01%	419
2025 Q4	$3.38K	Buy	5 +1	+25%	+$681	﹤0.01%	683
2025 Q3	$2.56K	Hold	4	–	–	﹤0.01%	807
2025 Q2	$2.15K	Sell	4 -4	-50%	-$1.91K	﹤0.01%	630
2025 Q1	$3.36K	Buy	8 +5	+167%	+$2.17K	﹤0.01%	527
2024 Q4	$1.24K	Buy	3 +2	+200%	+$877	﹤0.01%	509
2024 Q3	$505	Buy	+1	New	+$486	﹤0.01%	560

Other funds holding IDXX

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

MIM

Manitou Investment Management Toronto, Ontario, Canada $538M AUM 13.79% 1-Year Est. Return

BIAS

Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

HCM

Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return

AIM

Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Highline Wealth Partners's IDXX Position: Q2 2026 in Review

Highline Wealth Partners reduced its Idexx Laboratories (IDXX) stake by 52% in Q2 2026, selling an estimated $6.17K and leaving 10 shares worth $5.26K. The position accounts for ﹤0.01% of the portfolio, ranked #851.

Highline Wealth Partners first reported a position in IDXX in Q3 2024 and has held it in 8 quarters since. The position peaked at $11.8K in Q1 2026. 189 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Highline Wealth Partners held 10 shares of Idexx Laboratories worth $5.26K as of Q2 2026.
Highline Wealth Partners sold 11 Idexx Laboratories shares in Q2 2026, an estimated $6.17K.
Idexx Laboratories made up ﹤0.01% of Highline Wealth Partners's portfolio in Q2 2026, its #851 holding.
Highline Wealth Partners first reported a position in Idexx Laboratories in Q3 2024 and has held it in 8 quarters since.
Highline Wealth Partners's Idexx Laboratories position peaked at $11.8K in Q1 2026.
189 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.